Evidence map›Paper›PMID 32844245›Full record

ArticleArchives of toxicology2020

Epigenetic effects of low-level sodium arsenite exposure on human liver HepaRG cells.

Volodymyr P Tryndyak, Barbara Borowa-Mazgaj, Colleen R Steward, Frederick A Beland, Igor P Pogribny

Abstract read
PubMed Publisher
In one paragraph

Article in Archives of toxicology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.7field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Article
  3. Histone methylation in pre-cancerous liver diseases and hepatocellular carcinoma: recent overview.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2023
    Review
  4. Article
  5. Epigenomic reprogramming in iAs-mediated carcinogenesis.Advances in pharmacology (San Diego, Calif.) · 2023
    Article
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Volodymyr P Tryndyak *Division of Biochemical Toxicology, FDA-National Center for Toxicological Research, Jefferson, AR, USA.
Barbara Borowa-Mazgaj *Division of Biochemical Toxicology, FDA-National Center for Toxicological Research, Jefferson, AR, USA.
Colleen R StewardDivision of Biochemical Toxicology, FDA-National Center for Toxicological Research, Jefferson, AR, USA.
Frederick A BelandDivision of Biochemical Toxicology, FDA-National Center for Toxicological Research, Jefferson, AR, USA.
Igor P PogribnyDivision of Biochemical Toxicology, FDA-National Center for Toxicological Research, Jefferson, AR, USA. igor.pogribny@fda.hhs.gov.ORCID http://orcid.org/0000-0002-5248-9843
National Center for Toxicological Research · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic exposure to inorganic arsenic is associated with a variety of adverse health effects, including lung, bladder, kidney, and liver cancer. Several mechanisms have been proposed for arsenic-induced tumorigenesis; however, insufficient knowledge and many unanswered questions remain to explain the integrated molecular pathogenesis of arsenic carcinogenicity. In the present study, using non-tumorigenic human liver HepaRG cells, we investigated epigenetic alterations upon prolonged exposure to a noncytotoxic concentration of sodium arsenite (NaAsO

Indexed as

ArsenitesCell Line, TumorCell Transformation, NeoplasticClaudinsDNA DamageDNA MethylationEpigenesis, GeneticEpithelial-Mesenchymal TransitionGene Expression Regulation, NeoplasticHepatocytesHistonesHumansLiver NeoplasmsMutationSodium CompoundsArsenitesclaudin 14ClaudinsHistonessodium arseniteSodium CompoundsEpigeneticsHepaRG cellsHepatotoxicitySodium arsenite

Identifiers

PMID32844245
OpenAlexW3080768702

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.